2-(6-Methoxypyridin-2-yl)acetonitrile, 95.0%, 500mg

1H-Pyrrole-3-carbonitrile, 2-amino-4,5-dimethyl-1-[2-(1-piperazinyl)ethyl]-, 250mg

methyl (2-fluorophenoxy)acetate, 25g

Monoethyl Fumarate>97.0%(GC)(T)250g

cis-4-(Methoxycarbonyl)cyclohexanecarboxylic acid, 97%, 100g

(3-Fluoro-5-(2-methylpiperidine-1-carbonyl)phenyl)boronic acid, 97%, 1g

2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 5g

1-((2R,4S,5R)-4-((TRIETHYLSILYL)OXY)-5-(((TRIETHYLSILYL)OXY)METHYL)TETRAHYDROFURAN-2-YL)-5-VINYLPYRIMIDINE-2,4(1H,3H)-DIONE, 95%, 25mg

Methyl (R)-2-(((benzyloxy)carbonyl)amino)-2-cyclohexylacetate, 98%, 500mg

4-Chlorocinnoline, 95.0%, 100mg

1-Morpholino-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanone, 98%, 250mg

2-Bromo-4,6-difluorobenzoic acid, 97%, 100mg

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 1g